AbbVie (ABBV) stock Forecast for 2023, 2024, 2025, 2026
The forecast has been updated: December 6, 2023 7:24
AbbVie stock price online today
Analyst Target Price
169.88Dividend Date
15.02.2024Ex Dividend Date
12.01.2024Last Split Factor
Last Split Date
01.01.1970Should you buy or sell AbbVie stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2023, 2025, 2026?
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $169.88 target price for AbbVie stock stock.
Today 200 Day Moving Average is the resistance level (147.06 $).
50 Day Moving Average is the resistance level (144.13 $).
AbbVie stock monthly Forecast
Date | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
---|---|---|---|---|
08 Dec 23 | 146.36 | 144.60 | 147.29 | 1.86 % |
09 Dec 23 | 146.88 | 146.21 | 148.76 | 1.75 % |
10 Dec 23 | 146.82 | 145.97 | 149.17 | 2.19 % |
11 Dec 23 | 145.88 | 143.55 | 148.07 | 3.15 % |
12 Dec 23 | 145.30 | 144.20 | 147.31 | 2.16 % |
13 Dec 23 | 145.13 | 142.80 | 146.00 | 2.24 % |
14 Dec 23 | 146.03 | 144.83 | 146.79 | 1.35 % |
15 Dec 23 | 146.93 | 145.58 | 148.49 | 2.00 % |
16 Dec 23 | 148.69 | 147.36 | 150.45 | 2.10 % |
17 Dec 23 | 145.90 | 144.99 | 147.15 | 1.49 % |
18 Dec 23 | 145.58 | 144.12 | 147.82 | 2.57 % |
19 Dec 23 | 147.30 | 145.85 | 149.59 | 2.57 % |
20 Dec 23 | 149.92 | 148.75 | 151.96 | 2.16 % |
21 Dec 23 | 148.63 | 146.79 | 150.53 | 2.55 % |
22 Dec 23 | 147.53 | 146.38 | 148.47 | 1.43 % |
23 Dec 23 | 149.65 | 147.53 | 150.40 | 1.95 % |
24 Dec 23 | 148.64 | 147.60 | 149.38 | 1.21 % |
25 Dec 23 | 149.85 | 149.20 | 152.04 | 1.91 % |
26 Dec 23 | 148.54 | 146.19 | 150.02 | 2.62 % |
27 Dec 23 | 149.84 | 148.37 | 150.44 | 1.39 % |
28 Dec 23 | 149.15 | 147.21 | 151.00 | 2.57 % |
29 Dec 23 | 147.81 | 145.77 | 148.46 | 1.85 % |
30 Dec 23 | 146.81 | 144.93 | 148.24 | 2.29 % |
31 Dec 23 | 148.22 | 146.50 | 149.19 | 1.84 % |
01 Jan 24 | 147.71 | 146.88 | 148.72 | 1.25 % |
02 Jan 24 | 147.42 | 145.29 | 149.42 | 2.84 % |
03 Jan 24 | 147.62 | 146.12 | 148.77 | 1.82 % |
04 Jan 24 | 147.03 | 145.09 | 148.71 | 2.49 % |
05 Jan 24 | 145.83 | 144.28 | 147.84 | 2.47 % |
06 Jan 24 | 146.70 | 145.12 | 148.84 | 2.57 % |
ABBV daily forecast for this month
Estimated Average Forecasted AbbVie Price: 146.36 Positive intraday dynamics of the instrument is expected with 1.828% volatility is expected.
Pessimistic forecast: 144.60
Optimistic: 147.29
AbbVie stock forecast for 09.12.2023.
Estimated Average Forecasted AbbVie Price: 146.88 Positive intraday dynamics of the instrument is expected with 1.718% volatility is expected.
Pessimistic forecast: 146.21
Optimistic: 148.76
AbbVie stock forecast for 10.12.2023.
Estimated Average Forecasted AbbVie Price: 146.82 Negative intraday dynamics of the instrument is expected with 2.146% volatility is expected.
Pessimistic forecast: 145.97
Optimistic: 149.17
AbbVie stock forecast for 11.12.2023.
Estimated Average Forecasted AbbVie Price: 145.88 Negative intraday dynamics of the instrument is expected with 3.054% volatility is expected.
Pessimistic forecast: 143.55
Optimistic: 148.07
AbbVie stock forecast for 12.12.2023.
Estimated Average Forecasted AbbVie Price: 145.30 Negative intraday dynamics of the instrument is expected with 2.111% volatility is expected.
Pessimistic forecast: 144.20
Optimistic: 147.31
ABBV Forecast for 2024
Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
---|---|---|---|---|
Jan | 147.11 | 142.29 | 155.59 | 8.55 % |
Feb | 141.70 | 137.17 | 149.41 | 8.19 % |
Mar | 136.26 | 127.87 | 141.60 | 9.70 % |
Apr | 138.98 | 134.43 | 144.66 | 7.07 % |
May | 142.54 | 134.22 | 147.22 | 8.83 % |
Jun | 138.10 | 134.12 | 144.50 | 7.19 % |
Jul | 147.82 | 138.71 | 154.68 | 10.32 % |
Aug | 148.17 | 140.35 | 154.22 | 8.99 % |
Sep | 153.27 | 150.69 | 162.34 | 7.17 % |
Oct | 158.91 | 150.01 | 168.19 | 10.81 % |
Nov | 163.10 | 160.36 | 171.72 | 6.61 % |
Dec | 167.02 | 163.01 | 169.69 | 3.94 % |
AbbVie stock forecast for this year
AbbVie share price average forecast for Jan 2024 is: 147.114 The dynamics are positive.
AbbVie share price average forecast for Feb 2024 is: 141.701 The dynamics are negative.
AbbVie share price average forecast for Mar 2024 is: 136.259 The dynamics are negative.
AbbVie share price average forecast for Apr 2024 is: 138.984 The dynamics are positive.
AbbVie share price average forecast for May 2024 is: 142.543 The dynamics are positive.
AbbVie share price average forecast for Jun 2024 is: 138.095 The dynamics are negative.
AbbVie share price average forecast for Jul 2024 is: 147.817 The dynamics are positive.
AbbVie share price average forecast for Aug 2024 is: 148.172 The dynamics are positive.
AbbVie share price average forecast for Sep 2024 is: 153.269 The dynamics are positive.
AbbVie share price average forecast for Oct 2024 is: 158.909 The dynamics are positive.
AbbVie share price average forecast for Nov 2024 is: 163.104 The dynamics are positive.
AbbVie share price average forecast for Dec 2024 is: 167.019 The dynamics are positive.
AbbVie stock Forecast for 2025
Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
---|---|---|---|---|
Jan | 160.74 | 154.57 | 164.98 | 6.31 % |
Feb | 168.71 | 162.77 | 176.27 | 7.66 % |
Mar | 167.77 | 164.55 | 170.85 | 3.69 % |
Apr | 161.19 | 155.52 | 168.67 | 7.80 % |
May | 160.03 | 150.17 | 168.48 | 10.87 % |
Jun | 164.13 | 155.20 | 171.87 | 9.70 % |
Jul | 162.55 | 159.82 | 169.05 | 5.46 % |
Aug | 152.41 | 149.24 | 157.77 | 5.41 % |
Sep | 148.87 | 140.89 | 154.59 | 8.86 % |
Oct | 143.87 | 138.92 | 150.43 | 7.65 % |
Nov | 139.73 | 132.46 | 142.41 | 6.99 % |
Dec | 137.49 | 133.20 | 145.30 | 8.33 % |
AbbVie stock Forecast for 2026
Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
---|---|---|---|---|
Jan | 143.76 | 135.02 | 149.51 | 9.69 % |
Feb | 152.96 | 149.78 | 156.02 | 4.00 % |
Mar | 153.70 | 150.25 | 157.38 | 4.53 % |
Apr | 156.28 | 150.40 | 166.03 | 9.41 % |
May | 161.65 | 154.67 | 170.19 | 9.12 % |
Jun | 166.18 | 157.27 | 172.96 | 9.07 % |
Jul | 160.46 | 155.59 | 163.42 | 4.79 % |
Aug | 171.37 | 164.52 | 178.23 | 7.69 % |
Sep | 177.68 | 168.58 | 182.23 | 7.49 % |
Oct | 177.97 | 171.70 | 182.38 | 5.85 % |
Nov | 174.41 | 169.94 | 180.41 | 5.80 % |
Dec | 176.22 | 168.04 | 184.40 | 8.87 % |
AbbVie stock Forecast for 2027
Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
---|---|---|---|---|
Jan | 177.77 | 174.64 | 188.44 | 7.32 % |
Feb | 175.50 | 166.93 | 179.01 | 6.75 % |
Mar | 170.16 | 161.04 | 178.74 | 9.90 % |
Apr | 159.68 | 149.97 | 166.45 | 9.90 % |
May | 156.74 | 146.71 | 159.37 | 7.95 % |
Jun | 153.73 | 148.20 | 161.23 | 8.09 % |
Jul | 152.26 | 144.83 | 158.71 | 8.75 % |
Aug | 150.31 | 140.69 | 155.48 | 9.51 % |
Sep | 150.91 | 144.15 | 159.72 | 9.75 % |
Oct | 162.14 | 154.22 | 166.80 | 7.54 % |
Nov | 174.33 | 164.43 | 183.11 | 10.21 % |
Dec | 179.91 | 172.28 | 185.52 | 7.14 % |
AbbVie stock Forecast for 2028
Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
---|---|---|---|---|
Jan | 178.61 | 168.61 | 188.76 | 10.67 % |
Feb | 173.47 | 163.48 | 176.66 | 7.46 % |
Mar | 185.96 | 179.86 | 189.23 | 4.95 % |
Apr | 171.82 | 163.03 | 177.87 | 8.35 % |
May | 177.73 | 173.04 | 188.40 | 8.15 % |
Jun | 183.85 | 178.70 | 189.29 | 5.59 % |
Jul | 171.20 | 160.38 | 181.20 | 11.49 % |
Aug | 171.75 | 165.43 | 179.30 | 7.74 % |
Sep | 166.66 | 162.26 | 175.86 | 7.73 % |
Oct | 165.86 | 156.18 | 172.23 | 9.32 % |
Nov | 166.39 | 160.14 | 172.12 | 6.96 % |
Dec | 164.40 | 158.87 | 173.87 | 8.62 % |
AbbVie overview
AbbVie Address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, USMarket Capitalization
253 302 014 000 $EBITDA
27 993 000 000PE Ratio
39.31PEG Ratio
1.279Dividend Per Share
5.92Dividend Yield
0.043EPS
3.65Quarterly Earnings Growth YOY
-0.548Quarterly Revenue Growth YOY
-0.06Trailing PE
39.31Forward PE
12.95EV To Revenue
5.45EV To EBITDA
30.4552 Week High
162.7552 Week Low
128.2450 Day Moving Average
144.13200 Day Moving Average
147.06Shares Outstanding
1765540000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
Other Healthcare sector assets
Name | Symbol | Last Close Price | Change |
---|---|---|---|
Abbott Laboratories
|
ABT | 95.78 (23.10.2023) | -1.03 % |
AbbVie Inc.
|
ABBV | 144.57 (05.12.2023) | 0.29 % |
Aeterna Zentaris Inc.
|
AEZS | 2.87 (14.07.2023) | -1.03 % |
Allakos Inc.
|
ALLK | 4.65 (14.07.2023) | -2.11 % |
Allogene Therapeutics, Inc.
|
ALLO | 4.96 (14.07.2023) | -4.89 % |
Amgen Inc.
|
AMGN | 273.06 (23.10.2023) | -2.06 % |
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
Atara Biotherapeutics, Inc.
|
ATRA | 1.83 (14.07.2023) | -8.04 % |
Aurora Cannabis Inc.
|
ACB | 0.534 (14.07.2023) | -5.94 % |
Becton Dickinson and Company
|
BDX | 259.39 (14.07.2023) | -0.22 % |
Biogen Inc.
|
BIIB | 278.4 (17.07.2023) | -0.19 % |
Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 27.37 (20.10.2023) | 1.60 % |
BioNTech SE
|
BNTX | 92.52 (23.10.2023) | 1.77 % |
bluebird bio, Inc.
|
BLUE | 3.03 (14.07.2023) | -8.46 % |
Boston Scientific Corp.
|
BSX | 49.52 (13.10.2023) | 1.81 % |
Bristol-Myers Squibb Company
|
BMY | 61.85 (17.07.2023) | -0.15 % |
Canopy Growth Corp.
|
CGC | 0.3841 (14.07.2023) | -40.91 % |
Castle Biosciences, Inc.
|
CSTL | 12.8 (23.10.2023) | 0.00 % |
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 3.16 (07.01.2022) | -5.67 % |
Eli Lilly and Company
|
LLY | 242.27 (04.02.2022) | 0.00 % |
Emergent BioSolutions Inc.
|
EBS | 7.21 (14.07.2023) | -0.96 % |
Exelixis, Inc.
|
EXEL | 18.56 (17.06.2022) | 5.63 % |
G1 Therapeutics, Inc.
|
GTHX | 2.41 (14.07.2023) | -0.82 % |
Gilead Sciences, Inc.
|
GILD | 77.19 (14.07.2023) | 0.63 % |
GlaxoSmithKline plc
|
GSK | 34.53 (14.07.2023) | -0.78 % |
GoodRx Holdings, Inc.
|
GDRX | 7.46 (14.07.2023) | 1.77 % |
GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
Incyte Corp.
|
INCY | 61.08 (17.07.2023) | -1.10 % |
Inovio Pharmaceuticals, Inc.
|
INO | 0.5392 (17.07.2023) | 2.70 % |
Johnson & Johnson
|
JNJ | 166.11 (13.04.2023) | 1.34 % |
Medtronic plc.
|
MDT | 72.39 (23.10.2023) | -0.43 % |
Merck & Co., Inc.
|
MRK | 105.57 (17.07.2023) | -1.65 % |
Moderna, Inc.
|
MRNA | 121.35 (14.07.2023) | -4.15 % |
Novartis AG
|
NVS | 98.83 (14.07.2023) | 0.51 % |
Novavax, Inc.
|
NVAX | 8.68 (14.07.2023) | -6.06 % |
ObsEva SA
|
OBSV | 0.05 (14.07.2023) | 0.00 % |
OrganiGram Holdings Inc.
|
OGI | 1.49 (17.07.2023) | -4.49 % |
Pfizer Inc.
|
PFE | 30.84 (23.10.2023) | 0.62 % |
Regeneron Pharmaceuticals, Inc.
|
REGN | 721.61 (17.07.2023) | 0.43 % |
Sanofi
|
SNY | 52.68 (14.07.2023) | 1.07 % |
Schrodinger, Inc.
|
SDGR | 21.99 (23.10.2023) | 0.05 % |
Senseonics Holdings, Inc.
|
SENS | 0.875 (14.07.2023) | -3.90 % |
Sorrento Therapeutics, Inc.
|
SRNE | 0.35 (14.07.2023) | -0.28 % |
Stryker Corp.
|
SYK | 263.57 (23.10.2023) | -0.80 % |
Sundial Growers Inc.
|
SNDL | 1.42 (17.07.2023) | 1.43 % |
Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 8.18 (23.10.2023) | 0.74 % |
Thermo Fisher Scientific Inc.
|
TMO | 461.81 (23.10.2023) | -0.55 % |
Tilray, Inc.
|
TLRY | 1.69 (17.07.2023) | 1.81 % |
UnitedHealth Group, Inc.
|
UNH | 527.03 (20.10.2023) | -0.87 % |
Veeva Systems Inc.
|
VEEV | 177.96 (05.12.2023) | -0.59 % |
Zomedica Corp.
|
ZOM | 0.2114 (14.07.2023) | -5.41 % |
Zynerba Pharmaceuticals, Inc.
|
ZYNE | 1.3 (11.10.2023) | 0.00 % |
Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post.php on line 1205 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post.php on line 1205
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.